We use tools, such as cookies, to enable essential services and functionality on our site. We also use this to collect data on how our visitors interact with our site, products and services. By clicking accept, you agree to our use of these tools for advertising, analytics and support. I Accept Privacy Policy Cookie Policy

0
immunodiagnosticsystems
0
  • About IDS
    • Company Overview
    • Corporate History
    • Strategic Vision
    • Board of Directors
    • IDS Worldwide
    • IDS Values
    • Careers
    • News and Events
    • EUROIMMUN Products
  • Products
    Automated
    Manual
  • Instrumentation
    • IDS-iSYS Multi-Discipline Automated System
    • Specifications
    • Service & Support
  • Clinical Areas
    Bone Metabolism
    Calcium Metabolism
    CKD-MBD
    Growth
    Cartilage Markers
    Reproductive
    Autoimmunity
    Infectious Diseases
    Allergy
    Covid-19
    Sarcoidosis Assays
    Therapeutic Drug Monitoring
    Endocrine Hypertension
    Adrenal Function
  • Research Areas
    Animal Research
    Bone Turnover Markers
    Other Research Areas
  • COVID-19 Tests
  • Contact
0

Quotes

  • About IDS
    • Company Overview
    • Corporate History
    • Strategic Vision
    • Board of Directors
    • IDS Worldwide
    • IDS Values
    • Careers
    • News and Events
    • EUROIMMUN Products
  • Products
    Automated
    Manual
  • Instrumentation
    • IDS-iSYS Multi-Discipline Automated System
    • Specifications
    • Service & Support
  • Clinical Areas
    Bone Metabolism
    Calcium Metabolism
    CKD-MBD
    Growth
    Cartilage Markers
    Reproductive
    Autoimmunity
    Infectious Diseases
    Allergy
    Covid-19
    Sarcoidosis Assays
    Therapeutic Drug Monitoring
    Endocrine Hypertension
    Adrenal Function
  • Research Areas
    Animal Research
    Bone Turnover Markers
    Other Research Areas
  • COVID-19 Tests
  • Contact

Home » Archives for August 2007

Month: August 2007

  • All News
  • Company News
  • Event News
  • Industry News
  • Product News

Completion of Acquisition – Biocode Hycel

IDS, a leading producer of diagnostic testing kits, announces the completion of the acquisition of 99.93% of the ordinary share capital of Biocode Hycel S.A. (Biocode). As previously announced, the initial consideration for Biocode was €23,000,000, with €11,000,000 to be satisfied in cash, and the balance satisfied through the issue of 2,839,719 new Ordinary Shares […]

  • About Us
  • Products
  • Instrumentation
  • Clinical Areas
  • Research Areas
  • EUROIMMUN Products
  • Contact
Connect with us
Connect with us
Connect with us
  • Careers
  • News & Events
  • Sitemap
  • Cookie Policy
  • Terms of Use Policy
  • Privacy Policy
  • Acceptable Use Policy
  • Purchasing T&Cs
  • Terms of Sale
Please note our sites uses cookies for content personalisation, please review our cookie policy for further information.

To receive our Newsletter Document Name, please provide us with your following details:

To receive our Newsletter, please provide us with your following details: